Deutsche Bank’s Co-Diagnostics CODX Stock Holding History

Deutsche Bank’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4	Closed	-$1K	–	4267
2021 Q3	$1K	Buy	+4	New	+$1.17K	﹤0.01%	4366
2021 Q2	–	Sell	-617	Closed	-$177K	–	4629
2021 Q1	$177K	Sell	617 -54	-8%	-$21.6K	﹤0.01%	3700
2020 Q4	$187K	Buy	671 +190	+40%	+$70.4K	﹤0.01%	3501
2020 Q3	$196K	Buy	481 +42	+10%	+$21.6K	﹤0.01%	3227
2020 Q2	$255K	Buy	+439	New	+$200K	﹤0.01%	3020
2020 Q1	–	Sell	-178	Closed	-$4K	–	4398
2019 Q4	$4K	Buy	+178	New	+$5.25K	﹤0.01%	4699
2019 Q3	–	Hold	0	–	–	–	4935
2019 Q1	–	Sell	-32	Closed	–	–	5203
2018 Q4	$0	Buy	+32	New	+$2.09K	﹤0.01%	5183
2018 Q3	–	Sell	-7	Closed	-$1K	–	5374
2018 Q2	$1K	Buy	+7	New	+$571	﹤0.01%	5336

Other funds holding CODX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

ARC

Advisor Resource Council Dallas, Texas $355M AUM 30.05% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank's CODX Position: Q4 2021 in Review

Deutsche Bank sold out of Co-Diagnostics (CODX) in Q4 2021, closing a stake of 4 shares — an estimated $1K sold.

Deutsche Bank first reported a position in CODX in Q2 2018 and held it in 8 quarters. The position peaked at $255K in Q2 2020. 77 funds tracked by Wall St. Rank hold CODX as of Q4 2021.

Deutsche Bank reported no remaining Co-Diagnostics position as of Q4 2021 after selling out during the quarter.
Deutsche Bank sold 4 Co-Diagnostics shares in Q4 2021, an estimated $1K.
Deutsche Bank first reported a position in Co-Diagnostics in Q2 2018 and held it in 8 quarters.
Deutsche Bank's Co-Diagnostics position peaked at $255K in Q2 2020.
77 funds tracked by Wall St. Rank held Co-Diagnostics as of Q4 2021.

Based on Deutsche Bank's 13F filing for Q4 2021, filed 11 Feb 2022.